Products

MakeSuperAI

Discover startups. Meet founders. Find your next opportunity.

makesuperai.com DiscordEntertainment & Media / Directories & Curated Lists

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$199/mo
Higher than 96% of peersNiche median $13/mo
Creators
Makesuper AI
@makesuperai· 10 followers
Launched
5mo ago
2026-06-24 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@makesuperai
  • Launched on Product HuntLaunch

    Discover the Future of AI.

    Jun 24 · 5mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-02-26

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

MakeSuperAI Fundraise
$199/once

Trial: None · 1 paid tier ($199) · Observed 2026-11-06 · Pricing page

Entry price $199/mo, Higher than 96% of peers; “Directories & Curated Lists” median is $13/mo.View pricing benchmark

Website snapshots

Indexed 2026-06-24

Key pages

Desktop & mobile archive
www.makesuperai.com/home Snapshot 2026-11-06

Questions & evidence

How much does MakeSuperAI cost?
MakeSuperAI Fundraise: $199/once. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does MakeSuperAI get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is MakeSuperAI and what platforms does it support?
MakeSuperAI is catalogued under Directories & Curated Lists: Discover startups. Meet founders. Find your next opportunity. Supported platforms: Web.

Related products in this category

Entertainment & Media / Directories & Curated Lists

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.